Abstrakt

Acute pulmonary embolism (PE) is considered a life-threatening condition and, together with deep vein thrombosis, is part of the clinical picture of venous thromboembolism (VTE). Acute PE involves thromboembolic occlusion of the pulmonary arterial circulation. Acute PE has an annual incidence of 100 – 200 cases per 100,000 inhabitants and is the third leading cause of death from cardiovascular disease. This review article summarizes the current recommendations of German and international guidelines as well as the latest findings on risk stratification and treatment strategies. In particular, with regard to current data on reperfusion therapy using catheter-based reperfusion procedures in the acute phase, as well as with regard to prolonged anticoagulation in patients at increased risk of recurrent VTE.

Autoreninformation

Autoren

• L. Hobohm^{1, 2}
• K. Stannek¹
• K. Keller¹

Abteilungen

• ¹ Zentrum für Kardiologie, Kardiologie I, Universitätsmedizin Mainz,
• ² Centrum für Thrombose und Hämostase, Universitätsmedizin Mainz

Adresse

Priv.-Doz. Dr. med. Dr. med. univ. Lukas Hobohm
Zentrum für Kardiologie
Centrum für Thrombose und Hämostase (CTH)
Universitätsmedizin Mainz
Langenbeckstr. 1
55131 Mainz
Email: [email protected]

Citation